Key points are not available for this paper at this time.
Thrombolytic treatment in the CT-imaging suite (CIS) is a Target Stroke best practice, therefore it is hypothesized that taking the Telecart to CT and initiating treatment in CT will reduce door-to-needle (DTN) times.
Sambursky et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: